AGP Executive Report
Last update: 2 hours agoInfectious-Diseases Education Boost: SIDP and MAD-ID are teaming up for a more accessible, pharmacist-led infectious diseases education model, aiming to expand participation without adding more conferences. OPAT Monitoring Rethink: Clinicians are pushing beyond routine weekly labs for outpatient parenteral antimicrobial therapy, arguing for monitoring frequency tailored to patient risk and antibiotic toxicity. Cell/Gene Therapy Access Crunch: Aradigm CEO Will Shrank says payment and financial-risk arrangements for cures are at a breaking point, and his benefits platform is built to pool risk across payers, providers, patients, and manufacturers. Drug Trend Watch: Navitus reports specialty drugs and GLP-1s continue driving higher spending, with oncology utilization a key pressure point. Policy & Compliance: Texas Children’s Hospital is set to open a “detransition” clinic under a settlement tied to prior controversy, while Amgen expands its crackdown on 340B program misuse.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
